As healthcare challenges continue to grow, so does the need for innovative ways to meet them. Observe Medical develops medtech solutions that help ensure healthcare professionals and patients benefit from the highest standards of care safely and cost-effectively.
Oslo, 4 September 2020: Reference is made to the stock exchange announcement by Observe Medical ASA (the "Company") on 31 August 2020 regarding the exercise of employee share options and issue of 171,875 new shares in the Company. The NOK 44,687.50 share capital increase pertaining to the exercise of the employee share options has now…
Read moreOslo, 31 August 2020: The board of directors of Observe Medical ASA (the "Company") has resolved to increase the share capital of the Company following the completion of an exercise period for vested share options. 1. Exercise of employee share options In total 171,875 employee share options were exercised, giving the option holders the right…
Read moreOslo, 18 August 2020 – Observe Medical ASA (OSE: OBSERV) today released its interim report for the second quarter and first half year of 2020. The company’s initial product, Sippi, a unique and proprietary solution for digital automated urine monitoring in hospitals is in an early stage of commercialization. The company confirms its market estimate…
Read moreObserve Medical is a Nordic based medtech developer with development, quality, regulatory and commercial operations in Gothenburg, Sweden, and headquarters in Oslo, Norway.
The prevalence and cost of hospital acquired infection are growing challenges for healthcare facilities. Sippi infection inhibiting automated digital urine meter system from Observe Medical can help.